2019-nCoV Antigen Control (CLIA)
Manufactured by SHENZHEN YHLO BIOTECH CO., Ltd, China - http://www.szyhlo.com
Device identification number
1703
CE Marking
✓Yes
HSC common list
×No
HSC mutual recognition
×No
Format
Automated, Manual
Target
Antigen
Commercial Status
Commercialised
Last Update
2021-05-10 01:04:00 CET
Assay Type
Immuno-Antigen
Reader Required
Yes
Method
Immunoassay
Detection Principle
Chemiluminescence
LOD
0 AU
Calibration
Not evaluated
Crossreactivity
Not Evaluated
Precision
Evaluated
Accuracy
100 % (Antigen)
Reproducibility
Evaluated
Robustness
Evaluated
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements